Home| About us| My LA: login/register| For authors| For reviewers| Submit a paper
(close)

(Ctrl-click to select multiple journals)


How should we address you?

Your email address


 Yes, sign up now
 Sign up for general news too

Privacy Statement
 
 
 

Lymphoma and Chronic Lymphocytic Leukemias

Synopsis: An open access, peer reviewed electronic journal that covers basic and clinical research into lymphoma and chronic lymphoid leukemia.


Status: Under development with launch anticipated prior to mid-year.  Register for the newsletter to stay informed.  Applications for editorial board membership and journal peer reviewers are invited.

View factor
for journal
2664


About this journal

Aims and scope:

Lymphoma and Chronic Lymphocytic Leukemias is an open access, peer reviewed journal which covers all aspects of basic and clinical research into lymphoma and chronic lymphoid leukemia.

Topics may include detection, diagnosis, epidemiology, pathology, staging, prognosis, treatment and prevention of lymphoma, such as drugs, genetics, biomarkers, and the integration of different strategies. All types of lymphoma and related subjects are included; both Hodgkin’s and non-Hodgkin’s, including T- and B- Cell, natural killer cell and other lymphomas.

Editorial standards and procedures:

Submissions, excluding editorials, letters to the editor and dedications, will be peer reviewed by two reviewers.  Reviewers are required to provide fair, balanced and constructive reports.  

Under our Fairness in Peer Review Policy authors may appeal against reviewers' recommendations which are ill-founded, unobjective or unfair.  Appeals are considered by the Editor in Chief or Associate Editor.

Papers are not sent to peer reviewers following submission of a revised manuscript. Editorial decisions on re-submitted papers are based on the author's response to the initial peer review report.

National Institutes of Health Public Access Policy compliant:

As of April 7 2008, the US NIH Public Access Policy requires that all peer reviewed articles resulting from research carried out with NIH funding be deposited in the Pubmed Central archive.

If you are an NIH employee or grantee Libertas Academica will ensure that you comply with the policy by depositing your paper at Pubmed Central on your behalf. 

ISSN: 1179-2361


Bookmark journal

FACEBOOK
YAHOO! BUZZ
DIGG
LINKEDIN
Add to Mixx! MIXX
PERMALINK


 
 
 

Editor in Chief: Dr Mitchell Smith

Dr Mitchell Smith is Director of the Lymphoma Service in the Department of Medical Oncology at Fox Chase Cancer Centre, Pennsylvania, USA. Previously he was Assistant Professor of Medicine in the Division of Hematology and Oncology, at Wayne State University School of Medicine in Michigan. He has also conducted research through the Clinical Scholars Program at the Memorial Sloan-Kettering Cancer Centre in New York.

Dr Smith is currently investigating non-Hodgkin’s lymphoma and leukemia therapy, and in the past has received project funding from agencies such as NIH, the Leukemia Lymphoma Society of America and The Lymphoma Foundation. He has published over 60 articles, and contributed to 4 edited books or monographs on cancer. Dr Smith has been awarded a Lifetime Achievement Award by the Delaware Chapter of the Leukemia and Lymphoma Society of America. He serves on a number of boards and committees, including the ECOG Leukemia and Lymphoma subcommittees. He reviews for many journals on lymphoma and related oncology subjects.